Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Key: Novasep (0) Acquired (2)
hb-as02v (2 trials)
hepatitis b vaccine (recombinant) (Recombivax) (5 trials)
Key: Novasep (0) Acquired (3)
anti-cd3 conjugated to recombinant ricin a chain (1 trial)
anti-cd7 conjugated to recombinant ricin a chain (1 trial)
ebv vaccine (268664) (1 trial)
Key: Novasep (0) Acquired (1)
autologous hematopoietic stem cells (3 trials)
Trials (10 total)
Trial APIs (6 total)